September 10, 2010
| Digital Healthcare > Productivity Tools

Productivity Tools

Loading...

Change page: < >  |  Displaying page 1 of 5, items 1 to 10 of 47.

E-Prescribing Vendors Talk Back Digital HealthCare & Productivity | A month ago, acting Centers for Medicare and Medicaid Services (CMS) administrator Kerry Weems said that physicians can no longer use cost as an excuse for not switching to electronic prescribing. “The business case is turned around,” Weems said citing the affordability of the technology and reasonably small workflow changes it requires.

MGMA Meeting Pushes High Tech Patient ID Cards Digital HealthCare & Productivity | SAN DIEGO—The Medical Group Management Association (MGMA) will push the health insurance industry to standardize patient identification cards with magnetic stripes, bar codes, or embedded chips and has commissioned a study to quantify the potential savings for payers and providers alike.

e-Prescribing Crash Course Digital HealthCare & Productivity | Acting Centers for Medicare and Medicaid Services (CMS) administrator Kerry Weems called last week’s national conference on electronic prescribing a “crash course in e-prescribing.” The Oct. 7 event brought more than 1,400 physicians, pharmacists, practice administrators, health-IT professionals, vendors, and government representatives to Boston for an intensive study of the technology ahead of a Medicare incentive program that begins in January.

CMS Focuses on E-Prescribing Digital HealthCare & Productivity | BOSTON—With less than three months to go before Medicare starts paying incentives to physicians for electronic prescribing, the Centers for Medicare and Medicaid Services (CMS) is working frantically to get the word out about the benefits of such technology.

Affordable DNA Sequencing, Improved Imaging Technologies, Move the PM Ball Forward Digital HealthCare & Productivity | Slashing the cost of DNA sequencing is a prerequisite to making genomic medicine widely available and early this week, a new contender—Complete Genomics—emerged with a pledge to hit the $1000 genome price perhaps by this spring. My colleague and Bio-IT World’s editor-in-chief, Kevin Davies, was one the journalists to receive a comprehensive briefing and has charted the new company’s ambitious plans in an article posted online.

McKesson’s Personalized Medicine Prospects Digital HealthCare & Productivity | McKesson is jockeying for a prominent position in the rapidly evolving personalized medicine race, developing capabilities for next-generation electronic health records (EHRs), says Andrew Mellin, vice president for Predictive Care Solutions. The San Francisco-based health care giant formed this new group last year within the Life Sciences division, focusing in particular on tweaking its Horizon Clinicals products—decision support and physician order entry—to support advancements in genomics, genetic testing, and bioinformatics as they emerge.

MediNotes Acquisition to Open Doors to Physician Practices Digital HealthCare & Productivity | With its recently announced plans to take over MediNotes (West Des Moines, Iowa), Atlanta-based hospital systems vendor Eclipsys is making a push into the fast-growing but hard-to-reach market for independent physician practices

Global Image Search Digital HealthCare & Productivity | It’s certainly not the first Web site to be likened to YouTube for medicine, but Medting.com—formerly called MDPIXX—might just be the first truly global online repository of medical images and multimedia for physicians. The site, developed in Spain, also includes platforms for clinical exchange and telemedicine.

Survey Says Epocrates Enjoys iPhone Success Digital HealthCare & Productivity | If the iPhone is the killer app that pushes thousands of physicians to adopt health-IT (see “iPhone Will Change Health-IT, Says Datamonitor”), then the Epocrates Rx drug and formulary reference might be the software equivalent. At least that’s what San Mateo, Calif.-based Epocrates is claiming, based on the results of a customer survey.

Cancer Biomarkers Make Progress, Present Challenges Digital HealthCare & Productivity | The rush to develop effective biomarkers has perhaps been greatest in cancer and there have been notable successes. Clearly the need is great, but solid progress has also been accompanied by scientific and business model challenges

White Papers & Special Reports

sas_f0910
Rethinking Clinical Trials Data Integration
Sponsored by SAS

There is a gap between the need for data integration and fully integrated systems. To find out why, SAS and Pharmaceutical Executive conducted confidential telephone interviews with senior pharmaceutical executives and CROs. This article discusses recommendations on how to achieve optimal clinical data integration, based on those interviews.



ClearTrial_BriefingOn
eClinical Trial Technologies Revolutionizing Clinical Development Efficiency
Sponsored by ClearTrial
This Bio-IT World BriefingON report, sponsored by ClearTrial, presents a selection of recent stories from Bio•IT World and sister publication, eCliniqua, that illustrate how new technologies and approaches can have a profound impact on the management and execution of clinical trials.


oracle_RDC
Remote Data Capture:Acquisition and Analysis
Sponsored by Oracle

See why Electronic Data Capture (EDC) is gaining traction in the pharmaceutical
clinical trials arena. Today approximately half of all clinical trials are conducted
electronically, and the figure is rapidly rising. Report includes contributions from
Oracle Health Sciences, Pfizer, PPD, and C3i.

 



Life Science Webcasts & Podcasts

Bio-IT World & CHI

Impact of the 1000 Genomes Project on the Next Wave of Pharmacogenomic Discovery
1000genomeInterview with M. Eileen Dolan, Ph.D., Professor, Medicine, University of Chicago and Speaker at Next-Generation Sequencing Data Management, September 27-29, 2010, Providence, RI  

The 1000 Genomes Project aims to provide detailed genetic variation data on >1000 genomes from worldwide populations using the next-generation sequencing technologies. Some of the samples utilized for the 1000 Genomes Project are the International Hap-Map samples that are composed of lymphoblastoid cell lines (LCLs) derived from individuals of different world populations. The detailed map of human genetic variation promised by the 1000 Genomes project will allow a more in-depth analysis of the contribution of genetic variation to drug response. Future studies utilizing this new resource can greatly enhance our understanding of the genetic basis of drug response and other complex traits.


Download Now 



More Podcasts

Job Openings

mskc logo
Software Engineer – Computational Biology Center

Memorial Sloan-Kettering Cancer Center seeks an Engineer to design and develop complex data analysis systems in support of cancer genomics research projects at the Computational Biology Center. Qualified candidate will have a BA, 5+ years of software development experience and expert knowledge of Java, SQL, and HTML.

Apply: www.mskcciscareers.org.  Equal opportunity and affirmative action employer.



Loading...

For reprints and/or copyright permission, please contact The YGS Group, 3650 West Market Street, York, PA;

(717) 505-9701 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.